Greenberg, Steven M. http://orcid.org/0000-0003-1792-8887
Bacskai, Brian J.
Hernandez-Guillamon, Mar
Pruzin, Jeremy
Sperling, Reisa
van Veluw, Susanne J.
Article History
Accepted: 11 October 2019
First Online: 11 December 2019
Competing interests
: S.M.G. has served as a consultant or safety monitor for Alzheimer immunotherapy trials for Biogen, DIAN-TU and Roche. R.S. has served as a consultant or received clinical research funding from Biogen, Eisai, Eli Lilly, Janssen, Roche and Takeda. All other authors declare no competing interests.